Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Free Radical Biology & Medicine|May 15, 2002
EC-SOD and the response to inflammatory reactions and aging in mouse lungMarie Louise Sentman, Thomas Brännström, Stefan L MarklundCancer Immunity|July 9, 2013
NKG2D ligands as therapeutic targetsPaul Spear, Ming-Ru Wu, Marie-Louise Sentman, et al.Biorxiv : the Preprint Server for Biology|March 23, 2026
5xFAD-NSG mice: a preclinical Alzheimer model for human cell therapy studiesDavid J Graber, Marie-Louise Sentman, W James Cook, et al.The Journal of Biological Chemistry|December 27, 2005
Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutaseMarie-Louise Sentman, Micael Granström, Håkan Jakobson, et al.Cytotherapy|December 3, 2023
Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulationDavid J Graber, W James Cook, Marie-Louise Sentman, et al.Cells|September 13, 2025
Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG MiceDavid J Graber, W James Cook, Marie-Louise Sentman, et al.Future Oncology (London, England)|June 15, 2017
Exploiting natural killer group 2D receptors for CAR T-cell therapyBenjamin Demoulin, W James Cook, Joana Murad, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated MiceMarie-Louise Sentman, Joana M Murad, W James Cook, et al.Cytotherapy|September 6, 2018
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapyJoana M Murad, Susanne H Baumeister, Lillian Werner, et al.Pageof 1